Clinical Trial

Speech, Linguistic, Acoustic Markers in Parkinson's Disease

Study Description

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

We aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. We will administer various speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. We will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Diagnostic Test - Cognitive Battery

Participants will be asked to complete a series of cognitive testing (testing of concentration, memory, and other thinking abilities).

Behavioral - Voice, Speech and Language Analysis

Participants will be asked to perform speaking and reading tasks, which will be recorded. Participants will be asked to complete a laptop-based test of language comprehension.

Behavioral - Questionnaires and Clinical Assessments

Participants with Parkinson's disease will complete an examination of their symptoms and questionnaires assessing disease symptoms, mood and activities of daily living. Healthy controls participants will be asked to complete questionnaires on mood.

Genetic - DNA Analysis

Participants will have their blood drawn for DNA analysis.

Additional Information

Official Study Title

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

Clinical Trial ID

NCT04273672

ParticipAid ID

dJ6J9d